The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice

(2012) Angelo A Izzo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

(2012) Gabriella Aviello et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice

(2012) Rudolf Schicho et al.   PHARMACOLOGY

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity

(2012) Mireille Alhouayek et al.   TRENDS IN MOLECULAR MEDICINE

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

(2011) L. De Petrocellis et al.   Acta Physiologica

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

(2011) Ethan B Russo   BRITISH JOURNAL OF PHARMACOLOGY

Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae ): evidence for TRPA1-independent effects

(2011) Raffaele Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study

(2011) Adi Lahat et al.   DIGESTION

Cannabis use amongst patients with inflammatory bowel disease

(2011) Simon Lal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

(2011) George W. Booz   FREE RADICAL BIOLOGY AND MEDICINE

TRPA1 and Substance P Mediate Colitis in Mice

(2011) Matthias A. Engel et al.   GASTROENTEROLOGY

Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo

(2011) Gabriella Aviello et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Transient receptor potential channels as therapeutic targets

(2011) Magdalene M. Moran et al.   NATURE REVIEWS DRUG DISCOVERY

Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system

(2011) Peter Holzer   PHARMACOLOGY & THERAPEUTICS

The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis

(2010) JM Jamontt et al.   BRITISH JOURNAL OF PHARMACOLOGY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

(2010) Sabatino Maione et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes

(2010) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

(2010) Iain Brown et al.   CARCINOGENESIS

Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol☆

(2010) Gerald T. DeLong et al.   DRUG AND ALCOHOL DEPENDENCE

Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins

(2010) Aurelia Tubaro et al.   FITOTERAPIA

Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis

(2010) Takuya Yoshino et al.   INFLAMMATORY BOWEL DISEASES

Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*

(2010) Zlatko Mehmedic et al.   JOURNAL OF FORENSIC SCIENCES

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

(2009) Sumner H. Burstein et al.   AAPS Journal

Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells

(2009) Gabriella Aviello et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Cannabinoids in intestinal inflammation and cancer

(2009) Angelo A. Izzo et al.   PHARMACOLOGICAL RESEARCH

The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis

(2009) P. Grimaldi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

(2008) V Di Marzo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8

(2008) L. De Petrocellis et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS